Recommendations for Regulatory Reform, 57877-57878 [05-19788]
Download as PDF
Federal Register / Vol. 70, No. 191 / Tuesday, October 4, 2005 / Notices
Persons wishing to submit views to
the Council on any of the above topics
may do so by sending written
statements to Ann Bistay, Secretary of
the Consumer Advisory Council,
Division of Consumer and Community
Affairs, Board of Governors of the
Federal Reserve System, Washington,
DC 20551. Information about this
meeting may be obtained from Ms.
Bistay, 202–452–6470.
Board of Governors of the Federal Reserve
System, September 28, 2005.
Jennifer J. Johnson,
Secretary of the Board.
[FR Doc. 05–19781 Filed 10–3–05; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
[Document Identifier: OS–0990–New]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Office of the Secretary, Office
of Assistant Secretary for Planning &
Evaluation.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Office of the Secretary (OS), Department
of Health and Human Services, is
publishing the following summary of a
proposed collection for public
comment. Interested persons are invited
to send comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
Type of Information Collection
Request: Regular Clearance;
Title of Information Collection:
Survey of Frontline Supervisors of
Direct Service Workers Participating in
the Better Jobs Better Care
Demonstration;
Form/OMB No.: OS–0990–New;
Use: The President’s New Freedom
Initiative specifies goals for enhancing
the direct service workforce availability
and capability. There is currently a
major shortage of direct care workers—
AGENCY:
VerDate Aug<31>2005
16:55 Oct 03, 2005
Jkt 205001
nursing assistants, home health aides,
and personal care attendants—who
provide care and support to elderly
people with chronic diseases and
disabilities. Worker shortages are certain
to grow as the demand for long-term
care increases with the aging
population. Thus, recruitment and
retention of direct care workers has
become an issue of great interest to
policymakers, regulators and industry
leaders. The proposed survey will
ensure that HHS and other Federal,
state, and local agencies have timely
data available on the central role of
frontline supervisors in direct care
workers job quality and turnover.
Frequency: Reporting, on occasion;
Affected Public: Individuals or
households, business or other for profit,
not for profit institutions;
Annual Number of Respondents: 845;
Total Annual Responses: 845;
Average Burden Per Response: 30
minutes;
Total Annual Hours: 1,005;
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access the HHS Web
site address at https://www.hhs.gov/
oirm/infocollect/pending/ or e-mail your
request, including your address, phone
number, OMB number, and OS
document identifier, to
naomi.cook@hhs.gov, or call the Reports
Clearance Office on (202) 690–6162.
Written comments and
recommendations for the proposed
information collections must be
received within 30-days, of this notice
directly to the Desk Officer at the
address below: OMB Desk Officer: John
Kraemer, OMB Human Resources and
Housing Branch, Attention: (OMB #OS–
0990–NEW), New Executive Office
Building, Room 10235, Washington DC
20503.
Dated: September 21, 2005.
Robert E. Polson,
Office of the Secretary, Paperwork Reduction
Act Reports Clearance Officer.
[FR Doc. 05–19771 Filed 10–3–05; 8:45 am]
BILLING CODE 4151–05–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Recommendations for Regulatory
Reform
Department of Health and
Human Services, Office of the Assistant
Secretary for Planning and Evaluation.
ACTION: Notice of request for comments.
AGENCY:
SUMMARY: The House Appropriations
Committee Report 108–636 includes a
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
57877
provision for the Health and Human
Services Assistant Secretary for
Planning and Evaluation (HHS/ASPE)
and the Office of Management and
Budget (OMB) to establish an
interagency committee, to be
coordinated by HHS. The committee’s
role is to examine major federal
regulations governing the health care
industry and to make suggestions
regarding how health care regulation
could be coordinated and simplified to
reduce costs and burdens and improve
translation of biomedical research into
medical practice, while continuing to
protect patients. This committee will
examine the economic impact of the
major federal regulations governing the
health care industry, and will explore
both immediate steps and longer-term
proposals for reducing regulatory
burden, while maintaining the highest
quality health care and other patient
protections.
In accord with the House
Appropriations Committee’s intent,
ASPE and OMB are undertaking several
complementary activities. First, we are
establishing an interagency committee
to undertake a comprehensive review of
federal health care regulations,
guidance, and paperwork requirements
in order to identify areas for reform.
Second, we are planning to hold a series
of public meetings in order to hear
directly from health care administrators,
institutional providers, physicians,
practitioners, patients, and others about
the impact of regulations, and to
identify other potential areas for reform.
The public meetings will be held in
several cities across the country to
provide an opportunity for input.
Individuals may also submit written
comments, regardless of their ability to
attend the public meetings, for
consideration by the interagency
committee. Information about the
schedule of public meetings and
registration procedures will be available
on the Web site https://aspe.hhs.gov/
arrb.
In order to assist the committee in
studying regulatory impact and reform,
in this notice ASPE is also requesting
public nominations of federal health
care regulations that could be
coordinated and simplified to reduce
costs and burdens and improve the
translation of biomedical research into
medical practice. In particular,
commenters are requested to suggest
specific reforms to regulations, guidance
documents, or paperwork requirements
that would improve the delivery of
health care by increasing efficiency,
reducing unnecessary costs, removing
uncertainty, and increasing flexibility,
while maintaining or improving patient
E:\FR\FM\04OCN1.SGM
04OCN1
57878
Federal Register / Vol. 70, No. 191 / Tuesday, October 4, 2005 / Notices
safety and quality of care and other
patient protections. The emphasis is on
major regulations issued within the last
ten (10) years.
ASPE requests that commenters, in
the selection of which reform ideas to
submit, consider the extent to which (1)
Benefits (quantitative and/or qualitative)
are likely to exceed costs for the reform,
(2) benefits (quantitative and/or
qualitative) can be increased without
exceeding costs, (3) the suggested
change would improve patients’ health
and quality of care, (4) the agency or
multiple agencies have statutory
authority to make the suggested change,
and (5) the rule or program is a major
contributor to the regulatory burden
imposed on the health care sector.
While both legislative and
administrative reforms are welcome,
administrative reforms such as those
that require discretionary rulemaking
are more likely to be initiated in a
timely manner. The reforms may
include modifying, extending, or
rescinding regulatory programs,
guidance documents or paperwork
requirements.
Once we receive the nominations
from the public, HHS, in cooperation
with OMB, will assemble and evaluate
the reform nominations and discuss
each of them with the relevant HHS
Operating Divisions, taking into account
statutory, economic, public health, and
budgetary considerations.
ASPE requests that
nominations (including explanations of
the suggested reforms) be submitted in
writing electronically to ASPE at
ReducingRegulatoryBurden@hhs.gov
within 30 calendar days from the date
of publication of this notice in the
Federal Register.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Marty McGeein, Office of the Assistant
Secretary for Planning and Evaluation,
200 Independence Avenue, SW.,
Washington, DC 20201. Telephone:
(202) 690–6443.
Dated: September 20, 2005.
Michael J. O’Grady,
Assistant Secretary for Planning and
Evaluation (ASPE), HHS.
John D. Graham,
Administrator, Office of Information and
Regulatory Affairs (OIRA), OMB.
[FR Doc. 05–19788 Filed 10–3–05; 8:45 am]
BILLING CODE 4150–05–P
VerDate Aug<31>2005
16:55 Oct 03, 2005
Jkt 205001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–05–05CZ]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–371–5983 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Assessing Diabetes Detection
Initiative for Policy Decisions—New—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Type 2 diabetes is a chronic disease
that affects more than 18 million
Americans, approximately 5 million of
whom do not know that they have the
disease. As the disease progresses, it
often causes severe complications,
including heart disease, blindness,
lower extremity arterial disease, and
kidney failure. Native Americans,
African Americans, Latino Americans,
and some Asian Americans and Pacific
Islanders are disproportionately affected
by diabetes. Identifying persons who
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
have undiagnosed diabetes and treating
them could prevent or delay diabetes
complications.
In November 2003 the Diabetes
Detection Initiative (DDI) was launched
in 10 pilot sites around the U.S. to
identify a portion of the estimated 5
million people with undiagnosed Type
2 diabetes, targeting specific areas in
each of 10 locales in which residents are
likely to be at higher risk for Type 2
diabetes. Implementation of the DDI
involved distributing a paper-and-pencil
risk test. Individuals whose score
indicated that they were at an increased
risk for diabetes were advised to see
their regular doctor (or to schedule an
appointment at one of several clinics
that had agreed to participate in the
DDI) to receive a finger-stick or other
tests to confirm whether or not they
have diabetes. Whether or not the DDI
should be expanded to other
communities depends on the health
benefits and costs of the program. The
CDC is planning to conduct a study to
provide this critical information.
The planned study will assess the
resources used, the cost per case
detected, and the perceived benefit of
the DDI to participants. Data for the
economic assessment will be obtained
by conducting surveys of local DDI
implementation teams, leadership at
participating health clinics, and patients
at participating health clinics. The
results of the study will also provide
information needed for conducting a
more complete cost-effectiveness
analysis of screening for undiagnosed
diabetes.
The point-of-contact (Implementation
team member) in each of the 10 regions
will be sent a mail survey to collect
information regarding the staff time and
other resources used to implement the
DDI program (including the staff time
and resources used by community-based
organizations that participated in the
DDI implementation). These planning
and implementation activities include
participating in meetings and
conference calls, recruiting clinics and
community-based organizations to
participate in the DDI, distributing risk
tests, organizing health fairs and other
community events, and designing media
campaigns to promote the DDI.
The health clinic leadership survey
will be mailed to one person at each of
the 43 clinics that participated in the
DDI implementation. The survey will
collect information regarding the costs
associated with the clinic’s participation
in the DDI. These will include the
medical costs of providing care to
patients who visited the clinic as a
result of the DDI, staff time associated
with DDI planning and implementation,
E:\FR\FM\04OCN1.SGM
04OCN1
Agencies
[Federal Register Volume 70, Number 191 (Tuesday, October 4, 2005)]
[Notices]
[Pages 57877-57878]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-19788]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Recommendations for Regulatory Reform
AGENCY: Department of Health and Human Services, Office of the
Assistant Secretary for Planning and Evaluation.
ACTION: Notice of request for comments.
-----------------------------------------------------------------------
SUMMARY: The House Appropriations Committee Report 108-636 includes a
provision for the Health and Human Services Assistant Secretary for
Planning and Evaluation (HHS/ASPE) and the Office of Management and
Budget (OMB) to establish an interagency committee, to be coordinated
by HHS. The committee's role is to examine major federal regulations
governing the health care industry and to make suggestions regarding
how health care regulation could be coordinated and simplified to
reduce costs and burdens and improve translation of biomedical research
into medical practice, while continuing to protect patients. This
committee will examine the economic impact of the major federal
regulations governing the health care industry, and will explore both
immediate steps and longer-term proposals for reducing regulatory
burden, while maintaining the highest quality health care and other
patient protections.
In accord with the House Appropriations Committee's intent, ASPE
and OMB are undertaking several complementary activities. First, we are
establishing an interagency committee to undertake a comprehensive
review of federal health care regulations, guidance, and paperwork
requirements in order to identify areas for reform. Second, we are
planning to hold a series of public meetings in order to hear directly
from health care administrators, institutional providers, physicians,
practitioners, patients, and others about the impact of regulations,
and to identify other potential areas for reform. The public meetings
will be held in several cities across the country to provide an
opportunity for input. Individuals may also submit written comments,
regardless of their ability to attend the public meetings, for
consideration by the interagency committee. Information about the
schedule of public meetings and registration procedures will be
available on the Web site https://aspe.hhs.gov/arrb.
In order to assist the committee in studying regulatory impact and
reform, in this notice ASPE is also requesting public nominations of
federal health care regulations that could be coordinated and
simplified to reduce costs and burdens and improve the translation of
biomedical research into medical practice. In particular, commenters
are requested to suggest specific reforms to regulations, guidance
documents, or paperwork requirements that would improve the delivery of
health care by increasing efficiency, reducing unnecessary costs,
removing uncertainty, and increasing flexibility, while maintaining or
improving patient
[[Page 57878]]
safety and quality of care and other patient protections. The emphasis
is on major regulations issued within the last ten (10) years.
ASPE requests that commenters, in the selection of which reform
ideas to submit, consider the extent to which (1) Benefits
(quantitative and/or qualitative) are likely to exceed costs for the
reform, (2) benefits (quantitative and/or qualitative) can be increased
without exceeding costs, (3) the suggested change would improve
patients' health and quality of care, (4) the agency or multiple
agencies have statutory authority to make the suggested change, and (5)
the rule or program is a major contributor to the regulatory burden
imposed on the health care sector. While both legislative and
administrative reforms are welcome, administrative reforms such as
those that require discretionary rulemaking are more likely to be
initiated in a timely manner. The reforms may include modifying,
extending, or rescinding regulatory programs, guidance documents or
paperwork requirements.
Once we receive the nominations from the public, HHS, in
cooperation with OMB, will assemble and evaluate the reform nominations
and discuss each of them with the relevant HHS Operating Divisions,
taking into account statutory, economic, public health, and budgetary
considerations.
ADDRESSES: ASPE requests that nominations (including explanations of
the suggested reforms) be submitted in writing electronically to ASPE
at ReducingRegulatoryBurden@hhs.gov within 30 calendar days from the
date of publication of this notice in the Federal Register.
FOR FURTHER INFORMATION CONTACT: Marty McGeein, Office of the Assistant
Secretary for Planning and Evaluation, 200 Independence Avenue, SW.,
Washington, DC 20201. Telephone: (202) 690-6443.
Dated: September 20, 2005.
Michael J. O'Grady,
Assistant Secretary for Planning and Evaluation (ASPE), HHS.
John D. Graham,
Administrator, Office of Information and Regulatory Affairs (OIRA),
OMB.
[FR Doc. 05-19788 Filed 10-3-05; 8:45 am]
BILLING CODE 4150-05-P